ACEIs and ARBs and Their Correlation with COVID-19: A Review | IDR
An Overview of Generic Angiotensin Receptor Blockers
Figure 1 | ACE-I/ARB Therapy prior to Contrast Exposure: What Should the Clinician Do?
Impact of renin–angiotensin–aldosterone system inhibitors on COVID-19 | Hypertension Research
Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers in COVID-19 - The Centre for Evidence-Based Medicine
ACE inhibitors, angiotensin receptor blockers and endothelial injury in COVID‐19 - Tetlow - 2021 - Journal of Internal Medicine - Wiley Online Library
Molecules | Free Full-Text | From Angiotensin II to Cyclic Peptides and Angiotensin Receptor Blockers (ARBs): Perspectives of ARBs in COVID-19 Therapy
Cross-Reactivity of ACE Inhibitor–Induced Angioedema with ARBs
NKF KDOQI Guidelines
From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5) | Journal of the American College of Cardiology
Review of evidence on using ACEi and ARBs in patients with hypertension and COVID-19 | SpringerLink
Choice of drug therapy in primary (essential) hypertension - UpToDate
Angiotensin Receptor Blockers versus ACE Inhibitors: Prevention of Death and Myocardial Infarction in High-Risk Populations - Benjamin J Epstein, John G Gums, 2005
Therapeutic impact of the single fixed-dose combination with a high-dose angiotensin-receptor blocker and a low-dose thiazide diuretic in the management of hypertension: awaiting further accumulation of clinical evidence | Hypertension Research
Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers in COVID-19 - The Centre for Evidence-Based Medicine
Should Angiotensin-Converting Enzyme Inhibitors ever Be Used for the Management of Hypertension? | SpringerLink
ACE (Angiotensin-Converting Enzyme) Inhibitors/Angiotensin Receptor Blockers Are Associated With Lower Colorectal Cancer Risk | Hypertension
Aug 4, 2014: How does naloxone work to reverse the effects of ACE inhibitor toxicity? | Tennessee Poison Center | FREE 24/7 Poison Help Hotline 800.222.1222
COVID-19 and Use of Drugs Targeting the Renin-Angiotensin-System - American College of Cardiology
Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors—lessons from available evidence and insights into COVID-19 | Hypertension Research
How effectively do ACE inhibitors and ARBs prevent migraines? | MDedge Family Medicine
ACE2 as a potential therapeutic target for pandemic COVID-19 - RSC Advances (RSC Publishing) DOI:10.1039/D0RA08228G
Dual renin-angiotensin system inhibition for prevention of renal and cardiovascular events: do the latest trials challenge existing evidence? | Cardiovascular Diabetology | Full Text
A practical guide to antiproteinuric drugs in dogs
Comparison of the actions of ACE inhibitors and ARBs - UpToDate
